Eficácia e tolerância da azitromicina versus claritromicina no tratamento das infecções do tracto respiratório inferior

[1]  E. Swiatlo,et al.  In vitro activities of oral antimicrobial agents against penicillin-resistant Streptococcus pneumoniae: implications for outpatient treatment. , 1997, Southern medical journal.

[2]  G. Mccracken.  Microbiologic activity of the newer macrolide antibiotics. , 1997, The Pediatric infectious disease journal.

[3]  S. Block,et al.  Future indications for macrolides. , 1997, The Pediatric infectious disease journal.

[4]  B. Wolf,et al.  Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections , 1996, Antimicrobial agents and chemotherapy.

[5]  G. Campbell,et al.  Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses , 1996, Antimicrobial agents and chemotherapy.

[6]  J. Powers.  Properties of azithromycin that enhance the potential for compliance in children with upper respiratory tract infections. , 1996, The Pediatric infectious disease journal.

[7]  R. Yeates,et al.  Interaction between midazolam and clarithromycin: comparison with azithromycin. , 1996, International journal of clinical pharmacology and therapeutics.

[8]  Biebuyck Xa.  Comparison of Azithromycin and Co-Amoxiclav in the Treatment of Acute Tracheobronchitis and Acute Infectious Exacerbations of Chronic Bronchitis in Adults , 1996 .

[9]  J. Kalbfleisch,et al.  Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in Western Europe and in the USA , 1996 .

[10]  J. Golden,et al.  Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects , 1996, Antimicrobial agents and chemotherapy.

[11]  P. Gris.  Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study. , 1996, The Journal of antimicrobial chemotherapy.

[12]  T. Schaberg,et al.  Azithromycin--review of key chemical, pharmacokinetic and microbiological features. , 1996, The Journal of antimicrobial chemotherapy.

[13]  D. Pontani,et al.  Paediatric safety of azithromycin: worldwide experience. , 1996, The Journal of antimicrobial chemotherapy.

[14]  M. Nahata.  Drug interactions with azithromycin and the macrolides: an overview. , 1996, The Journal of antimicrobial chemotherapy.

[15]  J. Zachariah.  A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections. , 1996, The Journal of antimicrobial chemotherapy.

[16]  J. Eskola,et al.  Passively acquired anti-tetanus and anti-Haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancy. , 1996, The Pediatric infectious disease journal.

[17]  C. Dunn,et al.  Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections. , 1996, Drugs.

[18]  T. Quinn,et al.  In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae , 1996, Antimicrobial agents and chemotherapy.

[19]  J. Ramirez,et al.  Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia. , 1995, Archives of internal medicine.

[20]  S. Hopkins,et al.  Clinical tolerability and safety of azithromycin in children , 1995 .

[21]  S. Mclinn.  Double blind and open label studies of azithromycin in the management of acute otitis media in children: a review , 1995 .

[22]  H. Neu.  Otitis media: antibiotic resistance of causative pathogens and treatment alternatives , 1995 .

[23]  M. Nahata.  Pharmacokinetics of azithromycin in pediatric patients: comparison with other agents used for treating otitis media and streptococcal pharyngitis , 1995 .

[24]  R. Manfredi,et al.  Clinical comparative study of azithromycin versus erythromycin in the treatment of acute respiratory tract infections in children. , 1992, Journal of chemotherapy.

[25]  S. Hopkins.  Clinical toleration and safety of azithromycin. , 1991, The American journal of medicine.

[26]  G. Amsden.  Erythromycin, clarithromycin, and azithromycin: are the differences real? , 1996, Clinical therapeutics.